CPSE:GMAB
CPSE:GMABBiotechs

Genmab (CPSE:GMAB) Valuation Update Following New Epcoritamab Lymphoma Data from ASH 2025

Genmab (CPSE:GMAB) just put epcoritamab back in the spotlight by unveiling fresh ASH 2025 data across multiple lymphoma trials that sharpen the drug’s profile and give investors more to consider. See our latest analysis for Genmab. Those ASH readouts land at a time when momentum in Genmab’s shares is clearly building, with a roughly 32% year to date share price return and a 36% one year total shareholder return, in contrast with still negative three year total shareholder returns. If...
CPSE:PAAL B
CPSE:PAAL BConstruction

Per Aarsleff (CPSE:PAAL B) Margin Slippage Tests Bullish Undervaluation Narrative After Q3 FY 2025

Per Aarsleff Holding (CPSE:PAAL B) has posted another solid update for FY 2025, with third quarter revenue of DKK 5.8 billion and EPS of DKK 12.37, setting the tone for a year that is tracking steadily against last year’s performance. The company has seen quarterly revenue move between DKK 5.2 billion and DKK 5.8 billion over the last three quarters, while EPS has ranged from DKK 8.84 to DKK 12.37. This gives investors a clear view of how earnings are holding up as margins ease slightly from...
CPSE:DANSKE
CPSE:DANSKEBanks

How Investors May Respond To Danske Bank (CPSE:DANSKE) Ending U.S. AML Probation And Settlement Process

Danske Bank has completed its three-year corporate probation with the U.S. Department of Justice, closing all formal processes linked to anti-money laundering failures at its former Estonia branch and a US$2.00 billion settlement agreed in 2022. This conclusion removes a long-running regulatory overhang from one of Europe’s most high-profile financial crime cases, clarifying Danske Bank’s compliance position for regulators, clients, and investors. With the U.S. probation now concluded, we’ll...
CPSE:SCHO
CPSE:SCHOFood

Assessing Aktieselskabet Schouw (CPSE:SCHO)’s Valuation After Its New Share Buyback Programme Launch

Aktieselskabet Schouw (CPSE:SCHO) has kicked off a new share buy back programme, planning to repurchase up to DKK 120 million of stock through year end, which the company presents as a clear signal of management confidence. See our latest analysis for Aktieselskabet Schouw. The buyback news lands on top of a solid run, with the share price at DKK 626 and a roughly 8 percent 1 month share price return contributing to a stronger year to date trend and healthy multi year total shareholder...
CPSE:NOVO B
CPSE:NOVO BPharmaceuticals

Is Novo Nordisk Attractively Priced After Its Sharp 2024 Share Price Slide?

If you have been wondering whether Novo Nordisk is a bargain or a value trap at today’s price, you are not alone. This article is going to walk you through the key numbers that actually matter. The shares recently closed at 309.35, with a 3.4% gain over the last 7 days, a roughly flat -0.5% over 30 days, but a sharp slide of -51.6% year to date and -58.7% over the last year. This tells us the market’s view of its risk and growth potential has shifted dramatically, despite a still respectable...
CPSE:PNDORA
CPSE:PNDORALuxury

Pandora (CPSE:PNDORA): Reassessing Valuation After Accelerated CEO Transition and Leadership Changes

Pandora (CPSE:PNDORA) is back in focus after the board accelerated its leadership transition, moving Berta de Pablos-Barbier into the CEO seat earlier than planned. This shift could subtly reshape the jewelry maker’s strategy. See our latest analysis for Pandora. The leadership shake up is landing against a tough backdrop, with a roughly 46 percent year to date share price return in negative territory and a 42 percent negative total shareholder return over 12 months. However, the three year...
CPSE:RILBA
CPSE:RILBABanks

How Investors May Respond To Ringkjøbing Landbobank (CPSE:RILBA) Committing DKK 1 Billion To Share Buybacks

Ringkjøbing Landbobank recently reported that, under its ongoing share buyback programme running until 30 January 2026, it has repurchased 612,277 shares for up to DKK 1,000 million, equivalent to 4.04% of its share capital. This progress update highlights a substantial capital allocation towards reducing the share count, which can meaningfully influence ownership concentration and per-share metrics. We’ll now explore how this sizeable DKK 1,000 million buyback commitment shapes Ringkjøbing...
CPSE:JYSK
CPSE:JYSKBanks

Assessing Jyske Bank (CPSE:JYSK)’s Valuation After Its Strong Recent Share Price Rally

Jyske Bank (CPSE:JYSK) has quietly delivered a strong run for shareholders, with the stock up about 7% over the past month and roughly 18% in the past 3 months. That outperformance raises a clear question: does the current price still make sense? See our latest analysis for Jyske Bank. Zooming out, that recent momentum sits on top of a powerful trend, with a year to date share price return above 60% and a five year total shareholder return near 300%. This suggests sentiment has steadily...
CPSE:VWS
CPSE:VWSElectrical

Does Vestas Wind Systems Still Offer Upside After Its 80.1% One Year Surge?

Wondering if Vestas Wind Systems is still worth buying after its huge run up, or if you have already missed the best of the upside? You are in the right place if you want a clear view on what the current price really implies. Vestas has quietly staged a big comeback, with the share price up 6.5% over the last week, 10.2% over the past month, and a striking 63.8% year to date, translating into an 80.1% gain over the last year despite still being down over 3 and 5 years. Part of this momentum...
CPSE:UIE
CPSE:UIEFood

UIE (CPSE:UIE) Valuation Check as New Buybacks and Twin Dividends Reshape Shareholder Returns

UIE (CPSE:UIE) just lined up a double move for shareholders, launching parallel Safe Harbour and Block trade buyback programs while also setting both special and regular cash dividends payable in mid December. See our latest analysis for UIE. The combination of hefty buybacks and twin dividends comes after a strong run, with a 90 day share price return of 31.87 percent and a three year total shareholder return of 153.80 percent, signaling momentum rather than a one off spike. If you like how...
CPSE:FLS
CPSE:FLSMachinery

Broker Upgrade On Turnaround Progress Could Be A Game Changer For FLSmidth (CPSE:FLS)

Earlier this week, Danish engineering group FLSmidth was upgraded from "hold" to "buy" by ABG Sundal Collier, with the broker citing expectations of stronger financials, margin expansion and support from higher metal prices as the company exits a major restructuring phase under departing CEO Mikko Keto. The upgrade underscores how FLSmidth’s completed turnaround and exposure to improving metals markets are reshaping expectations for its order pipeline and profitability profile. We’ll now...
CPSE:VWS
CPSE:VWSElectrical

Vestas (CPSE:VWS) Valuation Check After Major New European Wind Turbine Orders and Growing Investor Optimism

Vestas Wind Systems (CPSE:VWS) has been busy, landing a string of European turbine orders from Germany to Poland and Italy, as well as a large undisclosed 660 MW EMEA deal that underlines sustained demand for its platforms. See our latest analysis for Vestas Wind Systems. These orders are landing against a strong backdrop, with the share price up 46.14 percent over the past 90 days and a hefty 63.51 percent year to date. The 1 year total shareholder return of 80.16 percent highlights how...
CPSE:SCHO
CPSE:SCHOFood

How Schouw’s New 2025 EBIT Outlook At Aktieselskabet Schouw (CPSE:SCHO) Has Changed Its Investment Story

Aktieselskabet Schouw & Co. recently issued consolidated guidance for 2026, projecting 2025 revenue of roughly DKK 16,000 million to DKK 17,000 million and EBIT of DKK 1,100 million to DKK 1,200 million. This fresh earnings outlook gives investors a clearer read on the conglomerate’s profit expectations across its aquaculture feed, industrial and materials businesses. Next, we’ll explore how this updated DKK 1,100–1,200 million EBIT outlook interacts with Schouw’s existing investment...